Cosmos Health Q2 revenue rises 29% to $19.0 million as net loss widens to $6.1 million
Cosmos Health reported second-quarter 2026 revenue of $18.99 million, up 28.8% from a year earlier, and said it was the highest second-quarter revenue in its history. The net loss widened to $6.09 million from $2.83 million, which the company attributed mainly to $2.65 million of non-cash charges, chiefly fair value adjustments on its financing arrangements.
Key points
- Q2 2026 revenue was $18.99 million, up 28.8% from $14.75 million; first-half revenue was $36.91 million, up 29.7%.
- Q2 2026 net loss was $6.09 million, compared with $2.83 million in Q2 2025; first-half net loss was $8.89 million versus $3.65 million.
- Q2 2026 gross profit was $1.51 million, up 29.9%; excluding $0.33 million of sales discount reversals, adjusted gross profit was $1.84 million, up 58.4%.
- The Board authorized a share repurchase of up to $5.0 million on June 26, 2026; the company has repurchased 5,112,000 shares for about $1.11 million as of this date.
The filing
Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 20, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.